ES8306322A1 - Perfeccionamientos introducidos en los procedimientos de preparacion de formas galenicas con accion retardada y libera- cion programada. - Google Patents
Perfeccionamientos introducidos en los procedimientos de preparacion de formas galenicas con accion retardada y libera- cion programada.Info
- Publication number
- ES8306322A1 ES8306322A1 ES497534A ES497534A ES8306322A1 ES 8306322 A1 ES8306322 A1 ES 8306322A1 ES 497534 A ES497534 A ES 497534A ES 497534 A ES497534 A ES 497534A ES 8306322 A1 ES8306322 A1 ES 8306322A1
- Authority
- ES
- Spain
- Prior art keywords
- galenical
- preparing
- delayed action
- methods
- programmed release
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
AJUSTE DEL PH EN UN PROCEDIMIENTO DE PREPARACION DE COMPRIMIDOS, GRANULOS Y SIMILARES, CON ACCION RETARDADA Y LIBERACION PROGRAMADA. LAS SOLUCIONES DE APLICACION DE LOS EXCIPIENTES, DE LOS REVESTIMIENTOS Y DE LOS ELEMENTOS CONSTITUTIVOS ACTIVOS, SE AJUSTAN A UN PH DESEADO, SI ES ALCALINO CON AYUDA DE BASES ORGANICAS Y/O MINERALES Y/O SALES BASICAS, SI ES ACIDO, CON AYUDA DE ACIDOS ORGANICOS Y/O DE SALES ACIDAS, DE ACUERDO CON EL GRADO DE INFLUENCIA QUE LA VARIACION DEL PH TENGA SOBRE EL PORCENTAJE DE SOLUBILIDAD DEL PRINCIPIO ACTIVO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7930085A FR2470599A1 (fr) | 1979-12-07 | 1979-12-07 | Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus |
Publications (2)
Publication Number | Publication Date |
---|---|
ES497534A0 ES497534A0 (es) | 1983-05-16 |
ES8306322A1 true ES8306322A1 (es) | 1983-05-16 |
Family
ID=9232512
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES497534A Expired ES8306322A1 (es) | 1979-12-07 | 1980-12-06 | Perfeccionamientos introducidos en los procedimientos de preparacion de formas galenicas con accion retardada y libera- cion programada. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5051262A (es) |
JP (1) | JPH0530804B2 (es) |
AT (1) | AT382513B (es) |
BE (1) | BE886510A (es) |
CH (1) | CH648207A5 (es) |
DE (1) | DE3050131T1 (es) |
ES (1) | ES8306322A1 (es) |
FR (1) | FR2470599A1 (es) |
GB (1) | GB2075343B (es) |
IT (1) | IT1134638B (es) |
WO (1) | WO1981001652A1 (es) |
Families Citing this family (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525345A (en) * | 1981-12-24 | 1985-06-25 | Verex Laboratories, Inc. | Constant order release, solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
FR2556964A1 (fr) * | 1983-12-23 | 1985-06-28 | Ile De France | Nouvelles formes galeniques du sulpiride utilisables par voie orale |
US4752470A (en) * | 1986-11-24 | 1988-06-21 | Mehta Atul M | Controlled release indomethacin |
SE509029C2 (sv) * | 1988-08-16 | 1998-11-30 | Ss Pharmaceutical Co | Långtidsverkande diklofenak-natriumpreparat |
JP2514078B2 (ja) * | 1988-08-22 | 1996-07-10 | エスエス製薬株式会社 | 圧縮成型製剤 |
JPH03145418A (ja) * | 1989-10-27 | 1991-06-20 | Sumitomo Pharmaceut Co Ltd | 塩基性薬物塩酸塩の徐放性製剤 |
CH678920A5 (es) * | 1989-11-14 | 1991-11-29 | Gergely Gerhard | |
IT1246383B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per il mascheramento del sapore di farmaci |
US5288505A (en) * | 1991-06-26 | 1994-02-22 | Galephar P.R., Inc., Ltd. | Extended release form of diltiazem |
FI101039B (fi) * | 1992-10-09 | 1998-04-15 | Eeva Kristoffersson | Menetelmä lääkepellettien valmistamiseksi |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
US5484607A (en) * | 1993-10-13 | 1996-01-16 | Horacek; H. Joseph | Extended release clonidine formulation |
US5458887A (en) * | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
GB9407386D0 (en) | 1994-04-14 | 1994-06-08 | Smithkline Beecham Plc | Pharmaceutical formulation |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
US20030109503A1 (en) * | 1995-06-06 | 2003-06-12 | Smithkline Beecham P.L.C. | Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics |
US5773031A (en) * | 1996-02-27 | 1998-06-30 | L. Perrigo Company | Acetaminophen sustained-release formulation |
US5830503A (en) * | 1996-06-21 | 1998-11-03 | Andrx Pharmaceuticals, Inc. | Enteric coated diltiazem once-a-day formulation |
JP2000516222A (ja) * | 1996-08-15 | 2000-12-05 | ロザン ファルマ ゲゼルシャフトミットベシュレンクテル ハフツング | 嚥下が容易な経口医薬組成物 |
US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
US20030124187A1 (en) * | 1997-02-14 | 2003-07-03 | Smithkline Beecham Laboratoires Pharmaceutiques, | Pharmaceutical formulations comprising amoxycillin and clavulanate |
IN186245B (es) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
US5948440A (en) * | 1997-12-17 | 1999-09-07 | Ranbaxy Laboratories Limited | Modified release matrix formulation of cefaclor and cephalexin |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
US20010055613A1 (en) | 1998-10-21 | 2001-12-27 | Beth A. Burnside | Oral pulsed dose drug delivery system |
US7250176B1 (en) | 1999-04-13 | 2007-07-31 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection |
US6294199B1 (en) | 1999-04-13 | 2001-09-25 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising administering amoxycillin |
DK200000602A (da) * | 1999-04-13 | 2000-10-14 | Beecham Pharm Pte Ltd | Ny fremgangsåde til behandling |
US6878386B1 (en) * | 1999-04-13 | 2005-04-12 | Beecham Pharmaceuticals (Pte) Limited | Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate |
CA2352211C (en) * | 1999-09-30 | 2009-03-24 | Edward Mendell Co., Inc. | Sustained release matrix systems for highly soluble drugs |
US20060153914A1 (en) * | 1999-12-10 | 2006-07-13 | Biovail Laboratories International S.R.L. | Chronotherapeutic diltiazem formulations and the administration thereof |
US7108866B1 (en) | 1999-12-10 | 2006-09-19 | Biovall Laboratories International Srl | Chronotherapeutic diltiazem formulations and the administration thereof |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6881420B2 (en) * | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
US6476006B2 (en) | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
DE10031043A1 (de) * | 2000-06-26 | 2002-02-14 | Bayer Ag | Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung |
AU2001292185A1 (en) | 2000-10-12 | 2002-04-22 | Beecham Pharmaceuticals (Pte) Limited | Formulation containing amoxicillin |
US6756057B2 (en) | 2000-10-12 | 2004-06-29 | Beecham Pharmaceuticals (Pte) Limited | Amoxicillin and potassium clavulanate dosage form |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
RU2322984C2 (ru) * | 2001-10-05 | 2008-04-27 | Комбинаторкс, Инкорпорейтед | Комбинации для лечения иммуновоспалительных расстройств |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
DE10209982A1 (de) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
US20030181488A1 (en) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof |
US6958161B2 (en) | 2002-04-12 | 2005-10-25 | F H Faulding & Co Limited | Modified release coated drug preparation |
US6913768B2 (en) * | 2002-09-24 | 2005-07-05 | Shire Laboratories, Inc. | Sustained release delivery of amphetamine salts |
CA2533178C (en) | 2003-07-21 | 2014-03-11 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
AU2004258953B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005016311A1 (en) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
JP2007502294A (ja) | 2003-08-12 | 2007-02-08 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
AU2004270170B2 (en) * | 2003-08-29 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
AU2004273830B2 (en) | 2003-09-15 | 2011-03-24 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
TW200517114A (en) * | 2003-10-15 | 2005-06-01 | Combinatorx Inc | Methods and reagents for the treatment of immunoinflammatory disorders |
PE20050445A1 (es) * | 2003-10-30 | 2005-06-18 | Bayer Consumer Care Ag | Forma de presentacion del naproxeno sodico |
JP2008505124A (ja) | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
JP2008508227A (ja) * | 2004-07-29 | 2008-03-21 | サノフイ−アベンテイス | 高ph依存性溶解度を有する有効成分の放出制御のための医薬品多層錠剤 |
US20070087056A1 (en) * | 2005-08-09 | 2007-04-19 | Claudia Guthmann | Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility |
CN102198273A (zh) * | 2005-08-22 | 2011-09-28 | 诺瓦提斯公司 | 包含pH依赖性药物、pH调节剂和阻滞剂的药物组合物 |
GB0517204D0 (en) * | 2005-08-22 | 2005-09-28 | Novartis Ag | Organic compounds |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
US20080003213A1 (en) * | 2006-05-22 | 2008-01-03 | Jan Lessem | Methods and compositions for the treatment of diseases or conditions associated with increased C-reactive protein, interleukin-6, or interferon-gamma levels |
US20070292503A1 (en) * | 2006-06-16 | 2007-12-20 | Gorissen Henricus R | Oral pharmaceutical composition of poorly water-soluble active substance |
EP1958615A1 (en) * | 2007-02-13 | 2008-08-20 | Bayer Schering Pharma Aktiengesellschaft | Solid pharmaceutical formulations of a homogeneous dispersion of active principles having pH-dependent solubility |
US20100172991A1 (en) * | 2007-06-08 | 2010-07-08 | Henry Joseph Horacek | Extended Release Formulation and Methods of Treating Adrenergic Dysregulation |
EP2155170A2 (en) * | 2007-06-08 | 2010-02-24 | Addrenex Pharmaceuticals, Inc. | Extended release formulation and method of treating adrenergic dysregulation |
EP2203174A4 (en) * | 2007-09-19 | 2010-09-29 | Combinatorx Inc | THERAPEUTIC REGIMES FOR THE TREATMENT OF IMMUNOINFLAMMATORY DISORDERS |
CA2709561A1 (en) * | 2007-12-17 | 2009-06-25 | Combinatorx, Incorporated | Therapeutic regimens for the treatment of immunoinflammatory disorders |
KR101752080B1 (ko) | 2007-12-28 | 2017-06-28 | 임팩스 라보라토리즈, 인코포레이티드 | 레보도파 방출 제어형 제제 및 이의 용도 |
BRPI0918492A2 (pt) * | 2008-09-09 | 2015-12-01 | Astrazeneca Ab | uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo |
SG176724A1 (en) | 2009-06-25 | 2012-01-30 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
US9011912B2 (en) | 2010-10-07 | 2015-04-21 | Abon Pharmaceuticals, Llc | Extended-release oral dosage forms for poorly soluble amine drugs |
BR112013029790A2 (pt) * | 2011-05-20 | 2017-01-17 | Aventis Pharma Sa | composição farmacêutica compreendendo cetoprofeno |
US9119793B1 (en) | 2011-06-28 | 2015-09-01 | Medicis Pharmaceutical Corporation | Gastroretentive dosage forms for doxycycline |
US9539214B2 (en) | 2011-12-28 | 2017-01-10 | Pozen Inc. | Compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
AU2013235266B2 (en) | 2012-03-20 | 2017-10-19 | Particle Dynamics International, Llc | Gelling agent-based dosage form |
US10842802B2 (en) | 2013-03-15 | 2020-11-24 | Medicis Pharmaceutical Corporation | Controlled release pharmaceutical dosage forms |
US10987313B2 (en) | 2013-10-07 | 2021-04-27 | Impax Laboratories, Llc | Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof |
KR102266091B1 (ko) | 2013-10-07 | 2021-06-17 | 임팩스 라보라토리즈, 인코포레이티드 | 레보도파 및/또는 레보도파의 에스테르의 점막-점착성, 제어 방출형 제제 그리고 이의 용도 |
CA2944900C (en) | 2014-04-04 | 2023-02-28 | Pharmaquest International Center, LLC | Disintegrating monolithic modified release tablets containing quadri-layer extended release granules |
CA3018328A1 (en) | 2014-10-31 | 2016-04-30 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
US11986449B2 (en) | 2020-12-22 | 2024-05-21 | Amneal Pharmaceuticals Llc | Levodopa dosing regimen |
Family Cites Families (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US443428A (en) * | 1890-12-23 | Drinking-fountain for poultry | ||
GB862376A (en) * | 1957-10-10 | 1961-03-08 | Pfizer & Co C | Sustained release pharmaceutical tablet |
US2993836A (en) * | 1958-02-20 | 1961-07-25 | Dow Chemical Co | Sustained release tablets |
US2971889A (en) * | 1958-03-18 | 1961-02-14 | Smith Kline French Lab | Press coated enteric tablets and process for preparing them |
US3136692A (en) * | 1961-06-30 | 1964-06-09 | Strong Cobb Arner Inc | Effervescent composition containing polyvinylpyrrolidone |
US3247066A (en) * | 1962-09-12 | 1966-04-19 | Parke Davis & Co | Controlled release dosage form containing water-swellable beadlet |
US3330729A (en) * | 1963-10-04 | 1967-07-11 | Goodrich Co B F | Sustained release tablet containing medicament admixed in a waterinsoluble acrylic acid cross-linked polymer and selected basic magnesium or calcium diluent |
GB1139991A (en) * | 1965-07-19 | 1969-01-15 | Armour Pharma | Stabilized enzyme composition |
CH434571A (de) * | 1966-07-05 | 1967-04-30 | Chemical And Pharmaceutical Pa | Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung |
GB1139869A (en) * | 1966-01-06 | 1969-01-15 | Moore Medicinal Products Ltd | Improvements in or relating to tablets |
FR7392M (es) * | 1966-07-19 | 1969-11-03 | ||
AT270071B (de) * | 1966-08-12 | 1969-04-10 | Roehm & Haas Gmbh | Dragierlack für Arzneiformen |
US3634584A (en) * | 1969-02-13 | 1972-01-11 | American Home Prod | Sustained action dosage form |
US3538214A (en) * | 1969-04-22 | 1970-11-03 | Merck & Co Inc | Controlled release medicinal tablets |
US3557279A (en) * | 1969-06-12 | 1971-01-19 | Merck & Co Inc | Microencapsulation form of an anti-inflammatory drug |
US3608063A (en) * | 1969-08-15 | 1971-09-21 | Gilbert S Banker | Molecular drug entrapment process and compositions |
US3629393A (en) * | 1969-09-11 | 1971-12-21 | Nikken Chemicals Co Ltd | Release-sustaining-tablet |
BE759520A (fr) * | 1969-11-28 | 1971-04-30 | Aspro Nicholas Ltd | Compositions d'aspirine |
DE2010416B2 (de) * | 1970-03-05 | 1979-03-29 | Hoechst Ag, 6000 Frankfurt | Oral anwendbare Arzneiform mit Retardwirkung |
US3653914A (en) * | 1970-03-20 | 1972-04-04 | Alberto Culver Co | Production of tablets |
US3676549A (en) * | 1970-09-30 | 1972-07-11 | Alza Corp | Administration of alkali metal salts of salicylamide |
US3764668A (en) * | 1970-09-30 | 1973-10-09 | Interx Research Corp | Compositions of salts of salicylamide |
US3885027A (en) * | 1971-04-12 | 1975-05-20 | West Laboratories Inc | Orally administered drug composition for therapy in the treatment of narcotic drug addiction |
NL7314765A (es) * | 1972-10-31 | 1974-05-02 | ||
US3954959A (en) * | 1973-03-28 | 1976-05-04 | A/S Alfred Benzon | Oral drug preparations |
GB1468172A (en) * | 1973-03-28 | 1977-03-23 | Benzon As Alfred | Oral drug preparations |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
JPS5157813A (en) * | 1974-11-14 | 1976-05-20 | Sankyo Co | Ll dooba mataha sonojudotaiseizaino seiho |
NZ179623A (en) * | 1975-01-06 | 1978-03-06 | Ciba Geigy | Pharmaceutical preparation containing a beta-receptor blocking compound, a compound regulating thrombocyte function and optionally an alpha-receptor blocking compund |
GB1509866A (en) * | 1975-06-10 | 1978-05-04 | Johnson & Johnson | Enteric coated digestive enzyme compositions |
FR2353285A1 (fr) * | 1975-09-17 | 1977-12-30 | Doms Laboratoires | Medicament vasodilatateur coronarien perfectionne |
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
HU174057B (hu) * | 1976-09-17 | 1979-10-28 | Richter Gedeon Vegyeszet | Sostav dlja pokrytij obespechivajuhhij uregulirovannuju otdachy aktivnogo vehhestva biologicheski aktivnykh preparatov i sposob poluchenija takikh preparatov s uregulirovannoj otdachej aktivnogo vehhestva |
LU77353A1 (es) * | 1977-05-16 | 1979-01-19 | ||
DE2735830A1 (de) * | 1977-08-09 | 1979-03-01 | Thomae Gmbh Dr K | Antithrombotische arzneimittelkombination und verfahren zu ihrer herstellung |
US4196187A (en) * | 1977-09-02 | 1980-04-01 | Eastman Kodak Company | Rumen-stable pellets |
US4181708A (en) * | 1977-09-02 | 1980-01-01 | Eastman Kodak Company | Rumen-stable pellets |
FR2401619A1 (fr) * | 1977-09-02 | 1979-03-30 | Eastman Kodak Co | Procede pour preparer des granules indegradables dans la panse des ruminants |
GB1594102A (en) * | 1977-09-26 | 1981-07-30 | Sankyo Co | Ingestible coating compositions |
US4180559A (en) * | 1978-01-05 | 1979-12-25 | Richardson-Merrell Inc. | Coated 1-(2-chlorodibenzo[b,f]oxepin-10-yl)-4-methylpiperazine compositions |
HU179474B (en) * | 1978-02-24 | 1982-10-28 | Laszlo Gyarmati | Process for preparing solid oral pharmaceutical compositons with increased length of activity and with a regulated release of the active material |
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
US4248872A (en) * | 1978-09-01 | 1981-02-03 | Horrobin David F | Method for the treatment of anxiety |
US4341563A (en) * | 1978-11-17 | 1982-07-27 | Sankyo Company Limited | Protective coating compositions |
US4173626A (en) * | 1978-12-11 | 1979-11-06 | Merck & Co., Inc. | Sustained release indomethacin |
CH647676A5 (fr) * | 1978-12-22 | 1985-02-15 | Donald E Panoz | Formes galeniques a usage oral, a liberation programmee et leurs procedes de preparation. |
US4261969A (en) * | 1979-05-03 | 1981-04-14 | World Health Organization | Controlled drug release composition |
US4289751A (en) * | 1979-06-29 | 1981-09-15 | Merck & Co., Inc. | Effervescent enteric-coated formulation of soluble form of erythromycin and therapeutic use thereof |
DE3000979A1 (de) * | 1980-01-12 | 1981-07-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue dipyridamol-retardformen und verfahren zu ihrer herstellung |
IT1148784B (it) * | 1980-04-09 | 1986-12-03 | Eurand Spa | Procedimento per la preparazione di microcapsule in un veicolo liquido |
US4344929A (en) * | 1980-04-25 | 1982-08-17 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
HU183408B (en) * | 1981-04-28 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing oral ratard pharmaceutical compositions |
DE3124090A1 (de) * | 1981-06-19 | 1983-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neue orale dipyridamolformen |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
BG36086A1 (en) * | 1982-01-19 | 1984-09-14 | Glbov | Method for inducing interferon |
JPS58134019A (ja) * | 1982-02-05 | 1983-08-10 | Ono Pharmaceut Co Ltd | プロスタグランジン含有持続放出型三層状フイルム製剤及びその製造方法 |
US4432965A (en) * | 1982-07-09 | 1984-02-21 | Key Pharmaceuticals, Inc. | Quinidine sustained release dosage formulation |
DK151608C (da) * | 1982-08-13 | 1988-06-20 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse |
DK152744C (da) * | 1982-08-13 | 1988-10-31 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat |
US4521401A (en) * | 1983-01-03 | 1985-06-04 | Verex Laboratories, Inc. | Constant release rate solid oral dosage formulations of quinidine |
IE55745B1 (en) * | 1983-04-06 | 1991-01-02 | Elan Corp Plc | Sustained absorption pharmaceutical composition |
IE56459B1 (en) * | 1983-12-21 | 1991-08-14 | Elan Corp Ltd | Controlled absorption pharmaceutical formulation |
IE56999B1 (en) * | 1983-12-22 | 1992-03-11 | Elan Corp Plc | Pharmaceutical formulation |
DE3586600T2 (de) * | 1984-02-10 | 1993-02-18 | Benzon Pharma As | Dosierungsform eine vielzahl mit einer diffusionshuelle ueberzogener einheiten enthaltend. |
DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
-
1979
- 1979-12-07 FR FR7930085A patent/FR2470599A1/fr active Granted
-
1980
- 1980-12-05 WO PCT/FR1980/000176 patent/WO1981001652A1/fr active Application Filing
- 1980-12-05 DE DE803050131T patent/DE3050131T1/de active Granted
- 1980-12-05 AT AT0912580A patent/AT382513B/de not_active IP Right Cessation
- 1980-12-05 CH CH5027/81A patent/CH648207A5/fr not_active IP Right Cessation
- 1980-12-05 GB GB8122407A patent/GB2075343B/en not_active Expired
- 1980-12-05 JP JP56500111A patent/JPH0530804B2/ja not_active Expired - Lifetime
- 1980-12-05 BE BE1/10060A patent/BE886510A/fr not_active IP Right Cessation
- 1980-12-06 ES ES497534A patent/ES8306322A1/es not_active Expired
- 1980-12-09 IT IT26515/80A patent/IT1134638B/it active
-
1986
- 1986-11-18 US US06/933,287 patent/US5051262A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
GB2075343A (en) | 1981-11-18 |
IT8026515A0 (it) | 1980-12-09 |
CH648207A5 (fr) | 1985-03-15 |
DE3050131T1 (de) | 1982-03-25 |
ES497534A0 (es) | 1983-05-16 |
FR2470599A1 (fr) | 1981-06-12 |
ATA912580A (de) | 1986-08-15 |
AT382513B (de) | 1987-03-10 |
GB2075343B (en) | 1984-10-10 |
JPS56501803A (es) | 1981-12-10 |
US5051262A (en) | 1991-09-24 |
FR2470599B1 (es) | 1983-03-25 |
JPH0530804B2 (es) | 1993-05-11 |
DE3050131C2 (es) | 1992-01-09 |
IT1134638B (it) | 1986-08-13 |
BE886510A (fr) | 1981-06-05 |
WO1981001652A1 (fr) | 1981-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8306322A1 (es) | Perfeccionamientos introducidos en los procedimientos de preparacion de formas galenicas con accion retardada y libera- cion programada. | |
HUT64595A (en) | Method for producing mammalian cytokine, il-11 | |
UA34419C2 (uk) | Ліофілізований препарат для ін'єкцій та спосіб інгібування росту пухлин | |
ES487151A1 (es) | Procedimiento de preparacion de nuevas formas galenicas de administracion de medicamentos por via oral, con liberacion programada | |
HUT44904A (en) | Herbicides comprising 3-phenyl-uracyl derivatives as active ingredient and process for producing the active ingredients and intermediaries thereof | |
EG14227A (en) | N-phenoxyalkyl imidazoles as selective infibitors of the thermoboxane synthetase enzyme,pharmaceutical compositions thereof and process for their preparation | |
NL930133I2 (nl) | Vaccin tegen hepatitis B virus, werkwijze en getransformeerde eukaryotische cellen en de bereiding van dat vaccin. | |
IL57901A (en) | Indanyl alkylsulphonyl derivatives,process for their preparation and pharmaceutical preparations containing them | |
ES8103972A1 (es) | Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina | |
IE791593L (en) | Acid addition salts of dipiperidinoandrostanes | |
HUT48217A (en) | Pesticides comprising 5-methylamino-1-arylpyrazole derivatives as active ingredient and process for producing the active ingredients | |
NL7603598A (nl) | Werkwijze voor het bereiden van preparaten voor het beinvloeden van de plantegroei alsmede de toepassing daarvan. | |
AU1577188A (en) | Biophysically derived ascomycetes, schizomycetes and yeast preparation, process for the manufacture thereof and fodder and plant hormones containing this preparation, and use of the preparations for skin treatment and probiotic activation | |
HUT49596A (en) | Herbicides comprising iminophenylthiazolidine derivatives as actie ingredient and process for producing the active ingredients | |
IL60080A (en) | Derivatives of 3-phenyl-2-dihydrothiazol-2-ylidene-3-oxo-propionitrile,process for their preparation,insecticidal preparations and methods for using them | |
DK0413793T3 (da) | Koncentrerede vandige emulsioner, en fremgangsmåde til deres fremstilling og deres anvendelse på pesticidområdet | |
DE2960836D1 (en) | N-substituted pyrazole derivatives, process for their preparation and n-hydroxyalkylpyrazoles obtained in the course of this process | |
PT72397A (en) | Process for the preparation of n,n-dialkyl-o-(pyrazol-5-yl)-carbamic acid derivatives and insecticide and nematicidecompositions thereof | |
CS189021B2 (en) | Insecticide,acaricide means and method of preparation of active agents | |
ZA706229B (en) | "2-chloroethane-(thiono)-phosphonic acid derivatives,process for their preparation,and their use for the regulation of plant growth | |
ZA765990B (en) | 0,0-diethyl-0-(n-methoxy-2-nitrobenzimidoyl)-thiono-phosphoric acid ester process for its preparation and its use asan insecticide and acaricide | |
EP0010250A3 (en) | Plant growth regulating agents, process for their preparation and their use in regulating plant growth | |
HUT45995A (en) | Pesticides comprising acyloxy-thiophene-urea derivatives as active ingredient and process for producing the active ingredients | |
DE3368611D1 (en) | 3,7-dichloroquinoline derivatives, process for their preparation and their use to prevent undesired plant growth | |
CS187383B2 (en) | Agent for regulation of the plant's growth and method of preparation of its active substance |